Amphetamine Carbamate Detection Through Carbonate Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for transdermal amphetamine compositions and delivery systems with low levels of amphetamine-related compounds, such as amphetamine carbamate and amphetacarbamate, and methods to detect and quantify these compounds, as current transdermal amphetamine products are not approved and existing methods are inadequate for potency and safety reasons.
Innovation Solution
Methods involving ion chromatography are developed to detect and quantify amphetamine carbamate and amphetacarbamate by converting these compounds into carbonate ions through a reaction with a base under inert conditions, using ion chromatography columns packed with alkanol quaternary ammonium cations and conductivity detectors to determine the presence and amount of amphetacarbamate based on a stoichiometric relationship.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If transdermal amphetamine compositions are developed, then amphetamine delivery is improved, but amphetamine-related compounds (carbamate and amphetacarbamate) are generated as unwanted byproducts
Solution Approach 1:
The patent applies preliminary action by pre-converting amphetamine into its carbamate form during the manufacturing process. This preliminary transformation allows the amphetamine to be stored and transported in a stable carbamate state, which then releases active amphetamine at the application site, thereby preventing the formation of unwanted amphetamine-related byproducts during storage and handling.
Solution Approach 2:
The patent employs inert atmosphere by conducting the carbamate formation reaction in an environment controlled to exclude moisture and other reactive substances. This inert environment prevents side reactions that would generate unwanted amphetamine-related compounds, ensuring high purity of the carbamate product while maintaining efficient amphetamine delivery capability.
2Measurement precision
If detection methods for amphetamine carbamate are developed, then measurement capability is improved, but analytical complexity increases
Solution Approach 1:
The patent uses an intermediary approach by converting amphetamine carbamate into a different chemical form (amphetamine and CO2) through thermal decomposition or chemical reaction before detection. This conversion step simplifies the detection process by transforming the difficult-to-detect carbamate into more readily detectable substances, thereby improving measurement precision while managing analytical complexity through a clear two-step process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate detection and quantification of amphetamine carbamate and amphetacarbamate in transdermal compositions, ensuring low levels of these compounds and improving the safety and efficacy of transdermal amphetamine delivery systems.
Implementation Method 1
converting these compounds into carbonate ions through a reaction with a base under inert conditions
Implementation Method 2
using ion chromatography columns packed with alkanol quaternary ammonium cations and conductivity detectors
Implementation Method 3
conductivity detectors to determine the presence and amount of amphetacarbamate
Data Source
AI summary
Described herein are the amphetamine-related compounds amphetamine carbamate (amphetammonium-amphetacarbamate) and amphetacarbamate, methods of making them, methods for detecting or quantitatively determining the amount of amphetacarbamate or amphetamine carbamate in a compositions, and ion chromatography columns useful in such methods.